FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Apollo Care, LLC(080452681)" | 71170-244 | 71170-244-25 | Vancomycin Hydrochloride | 3 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-254 | 71170-254-25 | Vancomycin Hydrochloride | 4 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-264 | 71170-264-25 | Vancomycin Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-194 | 71170-194-50 | Vancomycin Hydrochloride | 3.5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-184 | 71170-184-25 | Vancomycin Hydrochloride | 6 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-185 | 71170-185-50 | Vancomycin Hydrochloride | 3 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Apollo Care, LLC(080452681)" | 71170-204 | 71170-204-50 | Vancomycin Hydrochloride | 4 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-777 | 76154-777-73 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-779 | 76154-779-75 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-471 | 76154-471-15 | Norepinephrine Bitartrate | 16 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-473 | 76154-473-15 | Norepinephrine Bitartrate | 64 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-474 | 76154-474-15 | Norepinephrine Bitartrate | 16 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-475 | 76154-475-15 | Norepinephrine Bitartrate | 32 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-456 | 76154-456-15 | Phenylephrine Hydrochloride | 40 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-457 | 76154-457-15 | Phenylephrine Hydrochloride | 80 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-458 | 76154-458-15 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-459 | 76154-459-15 | Phenylephrine Hydrochloride | 160 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-460 | 76154-460-15 | Phenylephrine Hydrochloride | 200 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-808 | 76154-808-73 | Vasopressin | 1 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-806 | 76154-806-71 | Vasopressin | 1 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-489 | 76154-489-01 | Vasopressin | .4 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-480 | 76154-480-05 | Vasopressin | 1 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-487 | 76154-487-05 | Vasopressin | .4 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-477 | 76154-477-05 | Vasopressin | .2 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-479 | 76154-479-01 | Vasopressin | 1 [USP'U]/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-466 | 76154-466-15 | Epinephrine | 16 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-470 | 76154-470-15 | Epinephrine | 32 ug/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-781 | 76154-781-73 | Glycopyrrolate | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Athenex Pharma Solutions, LLC(078591072)" | 76154-782 | 76154-782-75 | Glycopyrrolate | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-042 | 71591-042-50 | Meloxicam | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-020 | 71591-020-01 | Metronidazole | 150 mg | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-017 | 71591-017-01 | Metronidazole Benzoate | 50 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-008 | 71591-008-01 | Metronidazole Benzoate | 100 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 80 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 80 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-009 | 71591-009-01 | Metronidazole Benzoate | 50 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-016 | 71591-016-01 | Metronidazole Benzoate | 100 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 160 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | Metronidazole Benzoate | 160 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-019 | 71591-019-01 | Metronidazole Benzoate | 40 mg | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-018 | 71591-018-01 | Metronidazole Benzoate | 80 mg | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-500 | 71591-500-50 | Ascorbic Acid | 500 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-045 | 71591-045-30 | Ponazuril | 227 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-043 | 71591-043-60 | Ponazuril | 90 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-012 | 71591-012-15 | Potassium Chloride | 2 meq/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | Praziquantel; Pyrantel Pamoate; Mebendazole | 22.7 mg; 65.376 mg; 50 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | Praziquantel; Pyrantel Pamoate; Oxantel Pamoate | 22.7 mg; 65.376 mg; 252 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-047 | 71591-047-01 | Prednisolone | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-048 | 71591-048-01 | Prednisolone | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-052 | 71591-052-01 | Secnidazole | 140 mg/1 mL | 2019-2 | valid | 2026-11-14 |